학술논문
Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China
Document Type
Article
Author
Source
In Respiratory Medicine May 2024 226
Subject
Language
ISSN
0954-6111